Skip to main content
Premium Trial:

Request an Annual Quote

Gencove Raises $10M in Series A Financing

NEW YORK – Low-pass genome sequencing firm Gencove said on Tuesday that it has closed a $10 million Series A financing round.

Lewis & Clark AgriFood led the round, joined by new and existing investors, including Spero Ventures, Techammer, Third Kind Venture Capital, and Version One Ventures. In a statement, Gencove said the funding would be used for product development and commercial growth and to build key business functions.

"Gencove's platform and datasets can help unlock the genetic underpinnings of our health and well-being," Larry Page, managing director at Lewis & Clark AgriFood, said in a statement. "We are thrilled to be part of a company whose technology has such broad consumer and industrial applications from agrigenomics, biotechnology, virology to medical diagnoses, disease susceptibility, and response to medical treatment."

The New York-based firm, a spinout from the New York Genome Center, has now raised a total of $16.2 million, including $3 million in March 2019. It offers low-pass sequencing and analytics software as a service.

The Scan

Looking for Omicron

NPR reports that SARS-CoV-2 testing in the US has gotten better but also that some experts say more needs to be done to better track the Omicron variant.

Holmes Alleges Abuse

The Associated Press reports that Theranos' Elizabeth Holmes has testified at her wire fraud trial that her business and romantic partner abused her.

Bit More Diverse, But More to Do

While Black and Hispanic patients are more likely to participate in cancer clinical trials than previously, they are still underrepresented, according to US News & World Report.

PNAS Papers on Yeast Gene Silencing, Zika Virus Inhibition, Immunoglobulin Hypermutation

In PNAS this week: gene silencing in Saccharomyces cerevisiae, possible neuroprotective role for SHFL in a mouse model of Zika virus infection, and more.